MedTrace Logo

Mitral Adjustable Annuloplasty Ring Feasibility and Safety Study

NCT00554151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2019-02-04

No results posted yet for this study

Summary

Evaluation of the technical feasibility and safety of the Mitral Adjustable Annuloplasty Ring.

Conditions

  • Mitral Valve Regurgitation

Interventions

DEVICE

Adjustable Annuloplasty Ring

The investigational device is intended for use in the treatment of mitral valve regurgitation.

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • A. Franka Borger, Prof. MD · University Leipzig Germany

  • A.P. Kappetein, Dr. · Erasmus MC, Universitair Medisch Centrum Rotterdam

  • R.J.M. Klautz, Dr. · Leids Universitair Medisch Centrum Lieden

  • Anno Diegeler, Prof, MD · Herz-und Gefäß-Klinik GmbH Bad Neustadt

  • Ottavio Alfieri, Prof, MD · Hospital San Rafaele

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-03-31
Completion
2010-04-30

Countries

  • Germany
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00554151 on ClinicalTrials.gov